10.04.2024 • NewsOrionCarbon Blackadditives

Orion Breaks Ground on Battery Materials Plant in Texas

Specialty chemicals company Orion, a producer of carbon black, broke ground on a battery materials plant in Texas, US. According to Orion, the facility will be the only one in the US producing acetylene-based conductive additives for lithium-ion batteries and other applications for the growing electrification.

Conductive additives enable a more efficient flow of electricity and extend the lifetime of lithium-ion batteries. The material also plays an essential role in high-voltage cables used for wind and solar farms.

The battery additives produced at the site in La Porte, southeast of Houston, will have only one-tenth of the carbon footprint of other commonly used materials, Orion claims. The acetylene for the additives produced at La Porte will be supplied by a neighboring site owned by Equistar Chemicals, a subsidiary of LyondellBasell.

Orion CEO Corning Painter said: “Our plant in La Porte will be a pivotal step toward strengthening the regional supply of conductive additives in the rapidly growing US battery market.”

According to Orion, key equipment procurement and off-site fabrication for the Pa Porte project are already at an advanced stage and start-up is expected in the second quarter of 2025.

© Orion
© Orion

Company

Orion S.A.

6 Route de Trèves
L-2633 Senningerberg
Luxembourg

Company contact







Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.